Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17 : analysis for the Global Burden of Disease Study 2017 by Local Burden Dis Diarrhoea et al.
Articles
www.thelancet.com   Vol 395   June 6, 2020 1779
Mapping geographical inequalities in childhood diarrhoeal 
morbidity and mortality in low-income and middle-income 
countries, 2000–17: analysis for the Global Burden of Disease 
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Summary
Background Across low-income and middle-income countries (LMICs), one in ten deaths in children younger than 
5 years is attributable to diarrhoea. The substantial between-country variation in both diarrhoea incidence and 
mortality is attributable to interventions that protect children, prevent infection, and treat disease. Identifying 
subnational regions with the highest burden and mapping associated risk factors can aid in reducing preventable 
childhood diarrhoea.
Methods We used Bayesian model-based geostatistics and a geolocated dataset comprising 15 072 746 children 
younger than 5 years from 466 surveys in 94 LMICs, in combination with findings of the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD) 2017, to estimate posterior distributions of diarrhoea prevalence, incidence, 
and mortality from 2000 to 2017. From these data, we estimated the burden of diarrhoea at varying subnational levels 
(termed units) by spatially aggregating draws, and we investigated the drivers of subnational patterns by creating 
aggregated risk factor estimates.
Findings The greatest declines in diarrhoeal mortality were seen in south and southeast Asia and South America, 
where 54·0% (95% uncertainty interval [UI] 38·1–65·8), 17·4% (7·7–28·4), and 59·5% (34·2–86·9) of units, 
respectively, recorded decreases in deaths from diarrhoea greater than 10%. Although children in much of Africa 
remain at high risk of death due to diarrhoea, regions with the most deaths were outside Africa, with the highest 
mortality units located in Pakistan. Indonesia showed the greatest within-country geographical inequality; some 
regions had mortality rates nearly four times the average country rate. Reductions in mortality were correlated to 
improvements in water, sanitation, and hygiene (WASH) or reductions in child growth failure (CGF). Similarly, most 
high-risk areas had poor WASH, high CGF, or low oral rehydration therapy coverage.
Interpretation By co-analysing geospatial trends in diarrhoeal burden and its key risk factors, we could assess 
candidate drivers of subnational death reduction. Further, by doing a counterfactual analysis of the remaining disease 
burden using key risk factors, we identified potential intervention strategies for vulnerable populations. In view of the 
demands for limited resources in LMICs, accurately quantifying the burden of diarrhoea and its drivers is important 
for precision public health.
Funding Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Across low-income and middle-income countries 
(LMICs), diarrhoea causes more than half a million 
childhood deaths annually.1 In addition to this staggering 
loss of life, more than 910 million childhood cases of 
diarrhoea per year2 are distributed unequally across the 
population, causing not only acute morbidity but also 
long-term disability in children who suffer repeatedly 
with enteric infections.3 National-level analyses of the 
burden of childhood diarrhoea, measured by both death 
rates and incidence, have exposed substantial variation. 
In LMICs in 2017, the incidence of diarrhoea ranged 
from less than one episode per child per year to more 
than four episodes per child per year.2 In the same 
population, the case-fatality rate of diarrhoea can vary 
from one per 10 000 infections to more than 20 per 
10 000 infections.4
WHO’s integrated Global Action Plan for Pneumonia 
and Diarrhoea (GAPPD) identified three approaches to 
reduce the burden of diarrhoea: protect, prevent, and 
treat.5 Healthy children are less likely to have severe 
diarrhoea episodes,6 so diarrhoeal burden can be reduced 
by prioritising good health practices from birth. As such, 
reducing general health risk factors, such as child growth 
failure (CGF) indicators of stunting, wasting, and under-
weight,4,7 can protect a child from diarrhoea. Preventing 
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illness by promoting vaccination and improved water, 
sanitation, and hygiene (WASH) can similarly reduce 
diarrhoeal burden.8,9 Finally, appropriate treatment, such 
as oral rehydration solution (ORS), the efficacy of which 
exceeds 90%,10 can substantially reduce death resulting 
from disease-associated dehydration.11,12
Distal determinants of diarrhoeal mortality, such as 
measurable indicators of child welfare,13 have been 
geospatially mapped at the local level in Africa, including 
under-5 mortality,14 CGF,15 and education levels of the 
broader population.16 Country-level assessment of these 
determinants can mask subnational variation and provide 
limited information with which to formulate policy.17 
Furthermore, mapping interventions such as malaria 
nets18 and vaccines19 has shown the positive effects of these 
strategies on reducing diseases. Subsequently, precise 
mapping of diarrhoea-related interventions, including 
ORS coverage20 and access to safe water and sanitation 
(Deshpande A, unpublished data), in addition to diarrhoea 
incidence and death, provides in-depth analysis to aid in 
the prevention of deaths associated with diarrhoea.
National trends in diarrhoeal burden are associated 
with (and in many cases driven by) national trends in 
risk factors associated with the protect, prevent, and treat 
strategy. Childhood stunting, poor sanitation access, and 
low ORS coverage are risk factors most strongly asso-
ciated with changes in diarrhoeal burden.4 To date, no 
comprehensive attempt has been made to quantify either 
the subnational variation in diarrhoea or these key risk 
factors across LMICs. Several isolated studies of sub-
national variation in diarrhoea,21 childhood stunting,15 
WASH,22 and ORS coverage23 have shown striking 
variation at the spatial scale investigated. However, 
without estimates designed to be comparable across 
space and time, it is difficult to analyse such scattered 
information as a cohesive body of knowledge.
Reducing morbidity and mortality could be accom-
plished by targeting regions with the highest mortality 
rate, or those with the greatest total number of deaths. At 
the national scale, for example, Central African Republic 
was estimated to have the highest childhood mortality 
rate attributable to diarrhoea globally, at 6·9 deaths per 
1000 children. Because of this country’s relatively small 
population, however, this rate translates to approximately 
4156 children dying per year.21 By contrast, in Nigeria, 
which has a much larger population than Central African 
Republic, an estimated 104 000 children a year die from 
diarrhoea, but the mortality rate is less than half that of 
Central African Republic (3·0 deaths per 1000 children).24 
A location within a country could have a relatively low 
risk of mortality but a sufficiently large population so it is 
a greater contributor to overall burden than other areas 
in that country. Thus, decisions aimed at optimum 
burden reduction might overlook those at highest risk. 
Mapping both rates and counts can aid in the design of 
intervention strategies that efficiently save lives while 
Research in context
Evidence before this study
In the Global Burden of Diseases, Injuries, and Risk Factors Study 
(GBD) 2017, diarrhoea was the third leading cause of death 
among children younger than 5 years and was reported to have 
caused an estimated 534 000 deaths. WHO’s integrated Global 
Action Plan for the Prevention and Control of Pneumonia and 
Diarrhoea calls for protection of children from disease by 
establishing good health practices, preventing infection from 
occurring, and treating infections when they occur. Over the 
past decade, large reductions in childhood mortality due to 
diarrhoea have been recorded across low-income and 
middle-income countries (LMICs), in part attributable to 
strategies to reduce child growth failure (CGF), improve water, 
sanitation, and hygiene (WASH), and increase access to oral 
rehydration therapy and vaccines. Several studies have recorded 
substantial between-country variation in both the likelihood of 
a child experiencing a diarrhoea episode and that episode 
resulting in death. To reduce the burden of childhood diarrhoea, 
the remaining subnational regions with the highest prevalence 
and those with the lowest levels of interventions should be 
identified.
Added value of this study
We present the first high-resolution subnational estimates of 
diarrhoeal morbidity and mortality from 2000 to 2017 in LMICs. 
We used Bayesian model-based geostatistics and an extensive 
geolocated dataset in combination with established methods 
from GBD 2017 for both burden estimation and risk factor 
association. We did a systematic assessment of local variation to 
estimate the distribution of diarrhoea prevalence, incidence, 
and mortality. Our estimates show considerable subnational 
variation in the diarrhoeal burden for children younger than 
5 years. We synthesised new subnational estimates of the key risk 
factors of diarrhoea to discern averted deaths attributable to 
improvements in these drivers of diarrhoeal morbidity and 
mortality. Finally, when focusing on subnational regions with the 
highest remaining burden, we identified not only which regions 
of the world have the highest diarrhoeal burden and continued 
geographical inequalities but also the subnational risk factors 
that require targeted interventions to alleviate this burden.
Implications of all the available evidence
By providing estimates of remaining diarrhoeal burden at 
various spatial scales, we have identified countries and locations 
that are still most in need of preventive and protective 
measures. Our results indicate that regions with the highest 
burden had varied exposure to select risk factors; however, 
similar to previous studies, most high-burden areas showed 
some combination of poor WASH, high CGF, and low oral 
rehydration solution coverage. In view of the limited resources 
in many LMICs, quantification of both the local burden of 
diarrhoea and its drivers is important to maximise impact.
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also highlighting entrenched geographical disparities in 
diarrhoeal burden.
Here, we present an analysis of local variation in 
diarrhoeal morbidity and mortality in children younger 
than 5 years across 94 LMICs between 2000 and 2017. 
We used Bayesian model-based geostatistics and an 
extensive geolocated dataset (describing 3 738 327 diar-
rhoea episodes across 15 072 746 children) in combination 
with methods from the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD) 2017 to esti-
mate posterior distributions of continuous continent-
wide surfaces of diarrhoea prevalence, incidence, and 
mortality.1,2 We then aggregated our estimates at second 
administrative-level units (eg, districts in Uganda or 
divisions in Kenya; henceforth referred to as units), to 
identify regions with the most pronounced rate of 
burden reduction versus those that continue to have 
higher-than-average burden. We combined this analysis 
with published estimates of subnational CGF variation15 
and new estimates of subnational variation in WASH 
(Deshpande A, unpublished data) and ORS20 to break 
down diarrhoeal burden. Finally, through these linked 
analyses, we identified regions most in need of tailored 
interventions to reduce the burden of this largely 
preventable disease.
Methods
Definitions
Diarrhoea episodes were defined as three or more loose 
stools over a 24-h period.4 Diarrhoea prevalence was defined 
as the point prevalence of children younger than 5 years 
with diarrhoea. Incidence was defined as the number of 
cases of diarrhoea in children younger than 5 years per 
child per year. Mortality was defined as the number of 
deaths among children younger than 5 years due to 
diarrhoea per child per year. Rates per 1000 are presented 
in the figures and represent prevalence, incidence, or 
mortality rates per child multiplied by 1000). Diarrhoea 
burden is used throughout this Article to refer to the 
combined burden of prevalence, incidence, and mortality.
Data
We included 94 LMICs in our analysis; these countries 
were defined according to the Socio-demographic Index 
(SDI), which assesses development based on education, 
fertility, and income.24 Where appropriate, we use 
designated ISO 3166-1 alpha-3 codes for countries. Our 
study complies with the Guidelines for Accurate and 
Transparent Health Estimates Reporting (GATHER) 
recommendations (appendix 1 pp 84–85).25
Surveys
We compiled 466 household surveys (including the 
Demographic and Health Survey [DHS], Multiple 
Indicator Cluster Survey [MICS], and other country-
specific surveys) from 2000 to 2017 with geocoded 
information from 207 021 coordinates corresponding 
to survey clusters and 17 954 subnational polygon 
boundaries. We included surveys that asked if children 
younger than 5 years had diarrhoea, typically within the 
preceding 2 weeks. Potential bias attributable to seasonal 
variation in diarrhoea was addressed, as described in 
appendix 1 (p 5). Data were vetted for representativeness 
at the national level and subnational level, as appropriate. 
Data inclusion, coverage, and validation are further 
described in appendix 1 (pp 3, 9).
Spatial covariates
We compiled 15 covariates that were indexed at the 
subnational level and could possibly be related to diarrhoea 
prevalence, including access to roads, ratio of child 
dependents (aged 0–14 years) to working-age adults (aged 
15–64 years), distance from rivers or lakes, night-time 
lights (time-varying covariate), elevation, population ratio 
of women of maternal age to children, population (time-
varying covariate), aridity (time-varying covariate), urban 
or rural (time-varying covariate), urban proportion of the 
location (time-varying covariate), irrigation, number of 
people whose daily vitamin A needs could be met, 
preva lence of under-5 stunting (time-varying covariate), 
prevalence of under-5 wasting (time-varying covariate), 
and diphtheria-tetanus-pertussis immunisation coverage 
(time-varying covariate). We also included the Healthcare 
Access and Quality Index,26 percentage of the population 
with access to improved toilet types, and percentage of 
the population with access to improved water sources 
(as defined by WHO and UNICEF’s Joint Monitoring 
Programme) as national-level time-varying covariates. 
We filtered these covariates for multicollin earity in each 
modelling region (appendix 1 pp 5–6) using variance 
inflation factor (VIF) analysis with a VIF threshold of 3.27 
Covariate information, including plots of all covariates, is 
detailed in the appendix 1 (pp 25–26, 90–96).
Statistical analysis
Geostatistical model
Prevalence data were used as inputs to a Bayesian model-
based geostatistical framework. Briefly, this framework 
uses a spatially and temporally explicit hierarchical 
logistic regression model to predict prevalence. Potential 
interactions and non-linear relations between covariates 
and diarrhoea prevalence were incorporated using a 
stacked generalisation technique.28 Posterior distributions 
of all parameters and hyperparameters were estimated 
using R-INLA version 19.05.30.9000.29,30 Uncertainty 
was calculated by taking 250 draws from the estimated 
posterior joint distribution of the model, and each 
uncertainty interval (UI) reported represents the 2·5th and 
97·5th percentiles of those draws. Models were run 
independently in 14 geogra phically distinct modelling 
regions based on the GBD 2010 study,31 and one country-
specific model in India. Analyses were done using R version 
3.5.0. Maps were produced using ArcGIS Desktop 10.6. 
Additional details are provided in appendix 1 (pp 6–8).
See Online for appendix 1
For the Joint Monitoring 
Programme see 
https://washdata.org/
For more on R see 
https://r-project.org
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Figure 1: Mapping of 
diarrhoea incidence among 
children younger than 
5 years in low-income and 
middle-income countries by 
second administrative-level 
unit, 2017
Estimated mean incidence rate 
per 1000 children in 2017 (A). 
Absolute deviation from mean 
incidence rate by country 
in 2017 (B). Annualised 
decrease in diarrhoea 
incidence rate from 2000 to 
2017 (C). Estimated mean 
number of cases of diarrhoea 
among children in 2017 (D). 
All panels are aggregated to 
the second administrative-
level unit. Maps reflect 
administrative boundaries, 
land cover, lakes, and 
population; grey-coloured grid 
cells were classified as barren 
or sparsely vegetated and had 
fewer than ten people per 
1 × 1 km grid cell, or were not 
included in these analyses.33–38
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Post estimation
Estimated prevalence was converted into incidence 
using an average duration of a diarrhoea episode of 
4·2 days4 (appendix 1 p 9). We converted incidence 
surfaces to mortality surfaces by multiplying the 
incidence values by country-specific and year-specific 
case-fatality rates (which did not vary subnationally). 
We calibrated our continuous prevalence estimates to 
those of prevalence, mortality, and incidence from 
GBD 2017. However, we did not calibrate prevalence or 
incidence in South Africa because of unreasonably low 
estimates in this location in the GBD 2017 study. We 
then calculated population-weighted aggregations of 
the 250 draws of diarrhoea prevalence, mortality, and 
incidence estimates at the country level, first admin-
istrative-level unit, and second administrative-level unit 
(hereafter referred to as unit). This calculation resulted 
in estimates for 24 143 units within 94 countries. 
Geographical inequalities were quantified as the relative 
difference between each unit and the respective country 
average. We also estimated inequality using the Gini 
coefficient,32 which summarises the distribution of 
each indicator across the population, with a value 
of 0 representing perfect equality and 1 representing 
maximum inequality (appendix 1 p 12).
Counterfactual analyses using diarrhoea risk factors
Following the GAPPD framework, we did a post-hoc 
counterfactual analysis using subnational estimates of 
risk factors according to GBD 2017, including reducing 
prevalence of childhood stunting and childhood wasting 
(protect), access to improved sanitation and improved 
water (prevent), and increasing ORS coverage (treat). 
Some known diarrhoea risk factors (eg, low coverage of 
rotavirus vaccine, or no or partial breastfeeding) were 
not included because subnational estimates are currently 
not available for all 94 LMICs included in this study. 
We used the counterfactual analysis to estimate the 
number of deaths averted because of changes in CGF 
and WASH risk factors (appendix 1 pp 61–62).
Model validation
Models were validated using source-stratified five-fold 
cross validation. Holdout sets were created by combining 
randomised sets of second administrative unit cluster-
level datapoints. Model performance was summarised 
by the bias (mean error), total variance (root-mean-
square error), 95% data coverage within prediction 
intervals, and correlation between observed data and 
predictions. When possible, estimates were compared 
against existing estimates. All validation procedures 
and corresponding results are provided in appendix 1 
(p 9).
Role of the funding source
The funder had no role in study design, data collection, 
data analysis, data interpretation, or writing of the 
report. RCR had full access to all data in the study and 
had final responsibility for the decision to submit for 
publication.
Results
Our model produced estimates of local diarrhoea 
prevalence, incidence, and mortality for 94 LMICs yearly 
from 2000 to 2017, showing subnational spatial and 
temporal variation. A large variation in diarrhoeal burden 
was seen, both between and within countries, and striking 
differences in trends were noted over time by location. 
Although, in many countries, rates of diarrhoeal morbidity 
and mortality were disproportionally high in less-populated 
rural areas, the absolute burden of diarrhoeal mortality 
was typically concentrated in highly populated urban 
centres. By integrating these subnational estimates of 
mortality with similar estimates of leading risk factors, 
improvements in WASH (Deshpande A, unpublished 
data) and prevention of CGF (relative to levels in 2000) 
were estimated to avert 46 000 (95% UI 32 000–170 000) 
and 245 000 (177 000–940 000) child deaths in 2017, respec-
tively. The full array of our model outputs is provided in 
appendix 2 (pp 1–950), and online.
Incidence of diarrhoea
In 2017, Yemen had the most units exceeding five cases of 
diarrhoea per child per year (124 units), with Afghanistan 
(16 units) the only other country with such high incidence 
(figure 1A). It is unsurprising that Yemen had the most 
subnational units with high incidence, because the 
country had had the highest national incidence of 
diarrhoea globally, with 4·7 (95% UI [4·0–5·7]) cases per 
child per year. In 2017, the highest incidence of diarrhoea 
for sub-Saharan Africa was in Cameroon (4·8 [95% UI 
2·9–7·4] cases per child per year in Mayo-Danay depart-
ment, Extrême-Nord); for Latin America the highest 
incidence was in Guatemala (4·7 [3·7–5·8] cases per child 
per year in San Antonio Suchitepéquez department, 
Suchitepéquez; and 4·4 [3·5–5·5] cases per child per year 
in San Miguel Panán department, Suchitepéquez); and 
for southeast Asia the highest incidence of diarrhoea was 
in Papua New Guinea (3·5 [2·7–4·5] cases per child per 
year in Koroba-Kopiago district, Hela). Massive variation 
within regions is exemplified in central Asia and south 
Asia, where the highest incidence of diarrhoea by country 
spanned from 2506th to 24 391st across all LMICs 
(2·8 [95% UI 2·1–3·6] cases per child per year in Moskva 
district, Khatlon, Tajikistan; and 0·7 [0·4–1·3] cases per 
child per year in Aşgabat district, Aşgabat, Turkmenistan; 
figure 1A). Maps of upper and lower bounds for the 
uncertainty on incidence can be found in appendix 1 (p 47).
As with variation between countries, substantial 
variation was seen within most countries. 16 countries 
had at least one unit with an estimated incidence of 
diarrhoea more than 1·0 case per child per year higher 
than the national average (figure 1B). The district of 
Darqad, Takhar, Afghanistan, had an incidence of 
For the full array of model 
outputs see https://preview.
healthdata.org/lbd/diarrhoea
See Online for appendix 2
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A
B
C
D
Absolute deviation from 
country mean (per 1000)
<–1·0 –0·5 0 0·5 >1·0
Annualised decrease in 
diarrhoea mortality (%)
0 3·6 7·5 11·5 >15·0
Diarrhoea mortality rate
(per 1000)
0 0·1 1·0 4·0 >7·0
Diarrhoea mortality count 
10 >10000
Figure 2: Mapping of 
diarrhoeal mortality among 
children younger than 
5 years in low-income and 
middle-income countries by 
second administrative-level 
unit, 2017
Estimated mean mortality rate 
per 1000 children in 2017 (A). 
Absolute deviation from the 
mean mortality rate by 
country in 2017 (B). 
Annualised decrease in 
diarrhoeal mortality rate 
from 2000 to 2017 (C). 
Estimated mean number of 
diarrhoeal deaths among 
children in 2017 (D). All panels 
are aggregated to the second 
administrative-level unit. 
Maps reflect administrative 
boundaries, land cover, lakes, 
and population; grey-coloured 
grid cells were classified as 
barren or sparsely vegetated 
and had fewer than ten people 
per 1 × 1 km grid cell, or were 
not included in these 
analyses.33–38
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6·3 (95% UI 4·2–9·5) cases per child per year, which was 
2·3 cases per child per year higher than the national 
average (4·0 [2·8–5·3] cases per child per year). 
Conversely, only nine countries had units with incidence 
less than 1·0 case per child per year lower than their 
country average (appendix 2 pp 3–4, 478–950). Countries 
with large relative geographical inequality include 
Guyana, where the rate in the Marudi council, Upper 
Takutu-Upper Essequibo, was 2·4 (95% UI 2·0–3·1) 
cases per child per year, which is much higher than the 
country average of 1·2 (0·9–1·5) cases per child per year. 
It is important to note that the comparison in Afghanistan 
also illustrates a technical difficulty in sum marising 
correlated uncertainty. In Afghanistan, the 95% UI for 
the estimated incidence of diarrhoea in Darqad overlaps 
that for average incidence across the country, but these 
UIs are based on summarising aggregations from 
draws of correlated incidence surfaces. In every draw 
from the posterior distribution of incidence, Darqad had 
an incidence at least 86·0% higher than that draw’s 
estimated country incidence.
The substantial reduction in overall diarrhoeal burden 
since 2000 has not translated into a consistent reduction 
in incidence of diarrhoea. 5729 (24%) of 24 139 units 
had an increase in childhood diarrhoea incidence 
from 2000 to 2017 (figure 1C). Laos in particular 
contained 24 units with annual rates of change in 
diarrhoea incidence exceeding 5% per year. Conversely, 
among all units that had decreases in incidence, Nigeria 
saw the greatest number of units (n=40) with annual 
declines in diarrhoea incidence of 7% or more.
Incidence data provide information on the per person 
risk of disease. However, some units with the highest 
incidence of diarrhoea are sparsely populated. On the 
other hand, many units with the highest incidence 
of diarrhoea and moderate rates of diarrhoea have 
considerable populations. For example, in 2017, five units 
in Punjab, Pakistan (Dera Ghazi Khan, Faisalabad, 
Gujranwala, Lahore, and Multan) were estimated to have 
more than 21 (95% UI 14·8–28·9) million cases of 
diarrhoea in children younger than 5 years (figure 1D). 
Each of these units had an incidence less than 
1·9 (95% UI 1·3–3·0) cases per child per year. By 
contrast, Wadhrah district in Hajjah, Yemen, had a 
high inci dence of diarrhoea (5·5 [95% UI 4·3–7·0] 
cases per child per year), but because of this district’s 
relatively small child population, there were only 
9890 (7766–12 723) cases of diarrhoea (figure 1D). These 
incidence data suggest that interventions focused on 
lowering the absolute burden of diarrhoea might best be 
focused on urban areas, although this focus risks 
exacerbating existing geographical disparities.
Mortality from diarrhoea
Similar to patterns noted previously on a subnational 
map of diarrhoeal mortality in Africa,21 substantial 
diarrhoeal burden was seen in several countries in the 
Sahel region of Africa, with Birao in Vakaga, Central 
African Republic, having the highest mortality rate glob-
ally of 8·2 (95% UI 6·8–9·7) deaths per 1000 children in 
2017 (figure 2A). Seven countries had at least one unit 
exceeding five deaths per 1000 children, and all were 
located in Africa. For 46 countries, the GAPPD goal of 
decreasing childhood diarrhoeal mortality to less than 
A Indonesia, 2000
B Indonesia, 2017
C DPeru, 2000 Peru, 2017
–100 0 50 150 >300
Relative deviation from 
country mean (%)
Figure 3: Relative geographical inequality of childhood diarrhoeal mortality in Indonesia and Peru in 2000 
and 2017
Relative deviation of second administrative-level units from country mean for Indonesia in 2000 (A), Indonesia 
in 2017 (B), Peru in 2000 (C), and Peru in 2017 (D). Maps reflect administrative boundaries, land cover, lakes, 
and population; grey-coloured grid cells were classified as barren or sparsely vegetated and had fewer than 
ten people per 1 × 1 km grid cell, or were not included in these analyses.33–38
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one death per 1000 children was achieved in every 
second administrative-level unit by 2017 (appendix 2 
pp 5–477). Global variation in diarrhoea mortality was so 
vast that rates for many countries remain several orders 
of magni tude lower than those in central sub-Saharan 
Africa (figure 2A).
Similar to incidence, substantial within-country vari-
ation was noted in diarrhoeal mortality. As previously 
highlighted in our Africa-focused analysis,21 some units 
in Nigeria in 2017 were far above the country average. 
Of the 100 largest deviations above the national mean 
mortality rate, 86 occurred in northern Nigeria (figure 2B). 
Only units in Chad, Kenya, and Nigeria had rates greater 
than one death per 1000 less than their country average 
mortality rate (figure 2B). When the analysis was done 
in terms of relative deviation from the mean, different 
patterns of subnational variation became apparent. 
Indonesia stood out as having many units within Papua 
that were more than three-fold the country average; in 
particular, the Boven Digoel Regency of Papua, Indonesia, 
was estimated to have a diarrhoeal mortality rate 3·4 times 
the national average (figures 3A, B). Similarly, 736 units 
of Mexico were estimated to have mortality rates more 
than double the national average (figure 2B). Although 
Nigeria had massive absolute deviations, units with the 
highest absolute deviations were 169·0% (95% UI 
114·2–256·5) the national average (figure 2B). Maps of 
upper and lower bounds for uncertainty on incidence 
can be found in appendix 1 (p 48).
Unlike incidence of diarrhoea, diarrhoeal mortality 
declined in most units from 2000 to 2017. 8658 (36%) of 
24 143 units showed reduced rates of childhood diarrhoeal 
mortality, by more than 10% per year (figure 2C). The 
greatest declines in diarrhoeal mortality were seen in 
south and southeast Asia and South America, where 
54·0% (95% UI 38·1–65·8), 17·4% (7·7–28·4), and 
59·5% (34·2–86·9) of units, respectively, recorded 
decreases in deaths from diarrhoea greater than 10%. 
Diarrhoeal mortality was estimated to have increased in 
only 112 (0·5%) units over this time, exclusively in 
Central African Republic, Indonesia, Kenya, South 
Sudan, and Tunisia. Although massive imbalances in 
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Figure 4: Geographical inequality of childhood diarrhoeal mortality at the 
second administrative-level unit
The left panel shows the range of relative deviation from the country mean 
diarrhoea mortality rate for each country in 2000 (upper bar) and 2017 (lower bar, 
coloured by GBD super-region). Each bar represents the range from the lowest to 
highest second administrative-level unit deviation for each country. The right 
panel shows LMICs with at least one death from diarrhoea per 10 000 children at 
the second administrative-level unit ranked by childhood diarrhoea mortality rate 
in 2017. Mean mortality rates are shown as dark grey dots and are national-level 
aggregations that correspond to the results shown in figure 3. Each bar represents 
the range from the lowest to highest second administrative-level unit childhood 
diarrhoeal mortality rate for each country in 2000 (upper bar) and 2017 (lower 
bar, coloured by GBD super-region). Country names in both panels are the 
designated ISO 3166-1 alpha-3 codes. GBD=Global Burden of Diseases, Injuries, 
and Risk Factors Study. LMICs=low-income and middle-income countries.
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mortality rates within Africa persisted in 2017, most 
diarrhoeal deaths in LMICs occurred outside of Africa. 
Importantly, because of the juxtaposition of mortality 
rate to population size, the five units with the largest 
number of diarrhoeal deaths were all outside of Africa, 
specifically in Punjab, Pakistan (Dera Ghazi Khan, 
Faisalabad, Gujranwala, Lahore, and Multan; figure 2D). 
By comparison, the total number of deaths in these five 
units was more than double the total estimated diarrhoeal 
deaths in Liberia, Rwanda, and Togo.
Geographical inequality in diarrhoeal mortality
Within analyses of geographical inequality, focusing on 
maximum deviations from the country mean can mask 
subnational variation in space and time. Two exemplars 
of this masking are Indonesia (where units with the 
greatest deviation changed over time) and Peru (where 
the shape of the distribution of inequality changed even 
though the maximum deviation remained mostly stable; 
figure 3). In 2000, the units within Indonesia farthest 
from the mean were all within the first administrative-
level units (provinces) of modern-day Gorontalo, Nusa 
Tenggara Barat, Sulawesi Barat, and Sulawesi Tengah, 
with the largest relative deviation in the East Lombok 
Regency in Nusa Tenggara Barat (101·4% the national 
mortality rate; figures 3A, 4). By 2017, units in Papua 
were almost four times the Indonesian national average 
(figures 3B, 4). Units in Papua went from not ranking in 
the 60 units with the highest deviation in Indonesia 
in 2000 to having the 29 units with the highest deviations 
from the country average in 2017.
In Peru, several units had substantial deviations from 
the national average in 2000. The maximum relative 
geographical inequality occurred in Requena province, 
Loreto, with 0·80 (95% UI 0·65–0·97) deaths per 1000, 
versus a country mortality rate of 0·4 (0·4–0·5) deaths 
per 1000 children, a relative deviation of 83·7%. Since 
2000, Peru has seen substantial reductions in diarrhoeal 
mortality, and yet, in 2017, mortality in Requena province, 
Loreto, was 56·8% higher than the country average. 
Although the maximum relative deviation increased 
over this period, the distribution of inequality shows a 
different pattern. In 2000, 58 of 196 provinces in Peru 
had mortality rates at least 20% higher than the country 
average (figure 3C); however, in 2017, only 34 provinces 
had mortality rates at least 20% higher than the country 
average (figure 3D).
Drivers of geographical inequality in diarrhoeal mortality
A risk factor can drive the risk of diarrhoeal mortality by 
increasing the chance that either a child is infected, 
infection develops into a disease episode, or an episode 
results in death. Both CGF and WASH risk factors were 
used as covariates in the diarrhoea prevalence model 
because they are predictive of infections that lead to 
diarrhoea.7,22 Conversely, ORS coverage was not used 
because there is clinical evidence that ORS prevents 
mortality from diarrhoea,11,12 but there is no evidence that 
it affects diarrhoea prevalence or incidence. Because of 
the possibility for circularity, post-hoc correlative analyses 
between the subnational variation in diarrhoeal mortality 
and the subnational variation in CGF and WASH must 
be interpreted carefully. However, consistent with the 
logic of previous risk factor analysis,3 excluding these 
known drivers of diarrhoea incidence would diminish the 
fit and usefulness of the output more than the potential 
loss of interpretation due to circularity. It is important 
to note that by using both stacked generalisation and 
the Gaussian process, which incorporates estimates of 
spatial and temporal autocorrelation, diarrhoeal mortality 
patterns are not a simple direct function of the risk factors 
used. Most importantly, the counterfactual analysis is 
based on externally derived risk ratios for each level of 
each risk factor.
To assess drivers of the temporal trends in diarrhoeal 
mortality, we did a counterfactual analysis by comparing 
the estimated number of diarrhoeal deaths in 2017 to the 
scenario in which these risk factors had been at their 
2000 levels. For the primary counterfactual analysis, 
we did not include ORS because only a few studies 
have quantified ORS efficacy precisely and, thus, there 
is no universally accepted risk ratio for its efficacy. 
A counter factual analysis that includes ORS is presented 
2000
2017
2000 and 2017
Location of lower 20%
A
(Figure 6 continues on next page)
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in appendix 1 (pp 61–62). Additional factors that affect 
death rates and counts, such as changes in population 
structure and size and sociodemographic factors, were 
kept at their 2017 levels. Reductions in CGF averted 
245 000 deaths, and 46 000 deaths were averted by 
improvements in WASH (figure 5D). In units where one 
or both risk factor groups improved from 2000 to 2017, 
we estimated 297 000 deaths were averted because of 
combined changes in WASH and CGF risk factors 
(figure 5B). The largest attributable relative reductions 
in diarrhoeal mortality in units where at least one child 
was estimated to have died from diarrhoea in 2017 were 
seen in India, Myanmar, Rwanda, and Somalia, where 
gains were mainly attributable to concurrent reductions 
in CGF (figures 5A, C). Conversely, the largest absolute 
attributable reductions in diarrhoeal mortality were in 
Ethiopia, India, Niger, and Pakistan. In Lahore, within 
the Punjab province of Pakistan, these gains were almost 
entirely due to improvements in WASH, whereas in the 
units within Ethiopia, India, and Niger, the averted 
deaths were almost entirely due to reductions in CGF 
(figures 5B, D). Although many regions that saw deaths 
averted because of WASH also had improvements 
associated with CGF, there were regions in Angola 
and Pakistan where the reduction in diarrhoea-related 
mortality was mainly driven by WASH (figure 5C). 
In 2000, across all LMIC units, 68·0–99·2% of childhood 
diarrhoeal deaths were attributable to either CGF or 
WASH risk factors. In 2017, the range increased slightly 
to 60·1–99·0% (appendix 1 pp 61–62).
Compared with other modelled regions, much of sub-
Saharan Africa had a disproportionally high burden of 
diarrhoeal disease. Inequality, as measured by the Gini 
coefficient across units within sub-Saharan Africa, 
remained mostly constant in sub-Saharan Africa from 
2000 (0·30) to 2017 (0·33). We identified units with child 
populations at highest risk of death due to diarrhoea, 
defined as units with 20% of the population in Africa 
living in areas with the highest mortality rates (figure 6A). 
No combination of risk factors that drove high diarrhoeal 
mortality was discernible; however, units had at least 
one risk factor at a high level (figures 6B–D). Of 565 units 
accounting for 20% of children with the highest 
diarrhoeal mortality risk in 2017, 447 were also among 
Figure 6: Second administrative-level units in sub-Saharan Africa with 
childhood mortality rates in the lower 20%
Second administrative units are coloured according to where children are most 
likely to die of diarrhoea, or the lower 20% (A). Scatter plots of mortality rates 
against ORS coverage (B),21 access to improved sanitation (C), and childhood 
stunting prevalence (D). The left axes are based on 2000 values whereas the 
right axes are based on 2017 values. The scale change in the y axis is due to 
substantial decline in mortality rates across most of sub-Saharan Africa. 
Because lower 20% is itself a relative distinction, scales are adjusted accordingly. 
Maps reflect administrative boundaries, land cover, lakes, and population; 
grey-coloured grid cells were classified as barren or sparsely vegetated and had 
fewer than ten people per 1 × 1 km grid cell, or were not included in these 
analyses.33–38 ORS=oral rehydration solution.
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those with the highest risk in 2000. The other 118 units 
that became relatively worse from 2000 to 2017 were 
predominantly in South Sudan (n=45), Central African 
Republic (n=39), and Madagascar (n=21). In units in 
South Sudan, although ORS decreased slightly on 
average (2·7%), there was a notable decline in average 
prevalence of childhood stunting across the 45 units 
(9·6%; figure 6D). As with high-burden areas in 2017, the 
risk factors that correlated with improvements from 
2000 to 2017 were varied. For example, of the 295 units 
that transitioned out of the lower 20% from 2000 to 2017, 
53 came from Liberia. In these units, surprisingly, both 
ORS coverage and access to improved sanitation declined 
on average from 2000 to 2017 (average ORS coverage 
declined by 14·1% and average access to improved 
sanitation declined by 11·7%; figures 6B, C). Conversely, 
and more consistent with the improvements in these 
units of Liberia, childhood stunting consistently improved 
from 2000 to 2017 (childhood stunting decreases ranged 
from 14·4% to 25·4%; figure 6D).
Discussion
Over the past 18 years, substantial reductions have been 
noted in diarrhoeal mortality, but these improvements 
have not been recorded uniformly across LMICs. 
Although only 112 (0·5%) of 24 143 units had increases in 
mortality rates from 2000 to 2017, 5729 (24%) units saw an 
increase in incidence of childhood diarrhoea over this 
period. While some units with high diarrhoeal burden in 
2000 have subsequently noted impressive reductions, 
other units with historically high diarrhoeal burden have 
seen some of the most meagre improvements. Globally, 
most of the diarrhoeal burden is in sub-Saharan Africa 
and south Asia, but we recorded substantial variation 
within countries in these subcontinents. Moreover, 
even in regions with relatively low diarrhoeal burden, we 
identified units that far exceeded their respective country’s 
averages. Our estimates identified the units of each 
country where diarrhoeal burden was disproportionally 
high, pinpointing the locations most in need of targeted 
interventions.
Identifying a country’s worst-performing units also 
leads to awareness of the extent of geographical 
inequality, measured by the range of relative deviation 
from the mean. It likewise pinpoints if these units are 
left behind consistently over time. In Peru, some metrics 
of geographical inequality seem to be mostly consistent 
from 2000 to 2017. However, deeper analysis into the 
distribution of burden across the country showed that 
more than half of its worst-performing units substantially 
improved relative to others in the country. Only a few 
Peruvian units east of the Andes seem to be left behind. 
Conversely, in Indonesia, the worst-performing units in 
2000 actually improved more than average, whereas 
units in Papua became substantially worse relative to the 
rest of the country, leading to units exceeding the country 
average by almost 350%.
The different subnational patterns that emerge between 
relative and absolute deviations are echoed when 
comparing units with the highest mortality rates versus 
those units where most children die from diarrhoea. 
Across all LMICs, even though units with the highest 
mortality risk were all in sub-Saharan Africa, the five units 
where most children died were all in Pakistan. These same 
patterns hold within many countries. In the Democratic 
Republic of the Congo, most deaths from diarrhoea 
occurred in the capital city of Kinshasa, where the death 
rate was 1·5 (95% UI 1·3–1·9) deaths per 1000 children; 
however, the second administrative-level unit with the 
highest death rate (Kazumba, Kasaï; 2·0 [1·6–2·4] deaths 
per 1000 children) had an estimated 307 (251–368) 
childhood deaths in 2017 because of its small population 
size (figure 2). When attempting to further reduce 
diarrhoeal burden in a country or region, interventionists, 
policy makers, and other stakeholders must consider and 
balance the needs of both locations with the highest risk 
and locations with the highest burden.
Changes in diarrhoeal burden are due to myriad related 
drivers, but findings of a study3 showed that CGF and poor 
access to improved WASH were most associated with 
global reductions in the burden of diarrhoea. Although 
there are other important risk factors for diarrhoea 
(eg, poor rotavirus vaccine coverage), we did a counter-
factual CGF and WASH risk factor analysis. Using newly 
available subnational estimates, we have provided a deeper 
understanding of the drivers of past success and location-
specific needs to prevent future deaths. Large portions of 
sub-Saharan Africa have seen improvements because of 
reductions in CGF. Likewise, reductions in diarrhoeal 
deaths in Ethiopia have coincided with improvements 
in access to better sanitation. We identified second 
administrative-level units of Ethiopia, India, Niger, and 
Pakistan where reductions in CGF and WASH risk factors 
since 2000 have averted more than 1000 childhood deaths 
due to diarrhoea. Some of the regions that have seen the 
slowest improvements can also be linked to risk factors. In 
much of Pakistan, for example, small improve ments in 
WASH have been overwhelmed by increases in CGF 
(figure 5). Although it is unlikely that risk factors will be 
eliminated completely, and thus counting all deaths still 
attributable to a risk factor is slightly misleading, we did 
identify patterns relating disproportionately high values 
of risk factors with dis pro portionally high burden. In 
sub-Saharan Africa, no combination of risk factors was 
found that needed reduction across the region; rather, in 
different locations of high burden, a different suite of risk 
factors seemed to be associated with the high risk of death 
due to diarrhoea (figure 6).
In the future, our analysis could aid in targeting of site-
specific interventions, for example, to units of India, 
Indonesia, and Nigeria that did worse than their respective 
country average and had higher than country-average 
levels of childhood stunting. Although nationwide cam-
paigns to reduce childhood stunting have a role in averting 
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further unnecessary deaths, focused interventions in 
the worst-performing units might reduce the recorded 
substantial geographical inequality in diarrhoeal burden. 
Our results did not always indicate that every unit needing 
improvements required reductions in all risk factors, even 
within one country. As an example, although most poorly 
performing units within Nigeria had lower than average 
access to improved sanitation and ORS coverage, almost 
10% of children in poorly performing units lived in 
locations estimated to have better than average sanitation 
and ORS coverage. Careful consideration of location-
specific risk factors is necessary to optimally design 
intervention programmes.
Limitations associated with our analysis include 
inherent biases in survey data, which are associated with 
data obtained with recall biases. There is also uneven data 
coverage in space and time, in particular from zones of 
conflict and political instability (eg, Afghanistan, Iraq, 
Pakistan, Syria, and Yemen). Regarding the geospatial 
modelling framework, our approach is designed to 
optimise out-of-sample predictive validity and, as such, it 
is difficult to do inferential analyses. Our spatial and 
temporal autocorrelation assumptions might smooth 
over focal epidemics. Additionally, our model does not 
distinguish differences in rates of disease or death by 
causes of diarrhoea because we are currently unable to 
fully model all causes of diarrhoea. For this study, we 
assume that the case-fatality rate is constant for any 
particular year within any particular country. This 
assumption is unlikely, but since it is more likely that the 
places with higher than average prevalence are likely to be 
the same places with a higher than average case-fatality 
rate, our observations about subnational inequality in 
diarrhoea mortality probably underestimate these quan-
tities. As previously mentioned, the risk factor analyses 
must be interpreted with care. CGF and WASH risk 
factors are used as covariates within the diarrhoea model, 
so it is unsurprising that the final diarrhoeal burden 
estimates correlate with those covariates. On the other 
hand, because of both the spatiotemporal smoothing that 
occurs through the Gaussian process and the stacked 
generalisation beforehand, it is not necessary for the final 
output to correspond with the covariates used in the 
regression. Although ORS was not used in the prevalence 
model, many of the base covariates used in diarrhoea 
(eg, elevation or population density) were used in the ORS 
model.
Our counterfactual analysis assumed that each risk 
factor affects diarrhoeal mortality and changes through 
time independently of all other risk factors. Accurately 
capturing and quantifying the covariation of these risk 
factors in space and time would further improve the use 
of that analysis. Our study also does not address the 
protective effect of breastfeeding with potential for the 
reduction of diarrhoeal burden.39 Breastfeeding can 
account for some of the lower rates of reduction in 
diarrhoea incidence and would be useful to investigate 
in future studies. Diarrhoea is a common symptom 
triggered by different causes and, to further focus 
preventive health-care strategies, a more in-depth 
analysis of diarrhoea causes should be done in future 
studies. Finally, despite the availability of vaccines to 
rotavirus, which is the leading cause of diarrhoea, we did 
not include coverage of this vaccine in our risk factor 
analysis because subnational estimates of rotavirus 
vaccine coverage are not yet available for all LMICs.
Because geospatial information is available for some 
causes of diarrhoea, estimating the subnational variation 
in those pathogens would help the interpretations and 
recommendations resultant from this work. Our current 
modelling framework aggregates ages to all children 
younger than 5 years but, in view of the strong relation 
between the case-fatality ratio and age, an age-specific 
model would be more informative. Our current frame-
work prioritises prediction over inference. There is an 
increased need in building inferential models that can 
be used to infer the effect of interventions. Finally, our 
model assumes that every child within a population is 
equally likely to become infected and, on infection, is 
equally likely to develop disease or die. It does not 
address the vicious cycle of repeated enteric infections 
in the same individual that causes more severe symp-
toms. Incorporating these dynamics into our modelling 
framework can improve accurate accounting of the long-
term burden of diarrhoea and quantification of those 
who are most vulnerable.
Every year, more than half a million children in LMICs 
die from diarrhoea; however, with treatment, most of 
these deaths can be averted. Our results serve as a 
new tool to pinpoint where these deaths occur. By 
establishment of good health practices from birth, 
children can be protected from enteric infections 
resulting in serious diarrhoeal episodes. Finally, by 
ensuring access to healthy environments, exposure 
to enteric pathogens can be prevented. Optimising 
reduction of diarrhoeal burden can be achieved by 
focusing on locations with the highest risk or those with 
the highest burden; either way, a detailed understanding 
of diarrhoeal morbidity and mortality, in addition to risk 
factors that drive diarrhoea, is necessary at the spatial 
scale at which policy is implemented. This work provides 
the data necessary to formulate effective policies and 
precision public health programmes to ultimately stop 
the preventable loss of so many young lives.
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